Inhibrx Market Cap

Inhibrx has a market cap or net worth of $1.63 billion as of April 24, 2024. Its market cap has increased by 87.28% in one year.

Market Cap

1.63B

Enterprise Value

1.56B

1-Year Change

87.28%

Ranking

#2079

Market Cap Chart

Since the IPO on August 19, 2020, Inhibrx's market cap has increased from $606.13M to $1.63B, an increase of 168.19%. That is a compound annual growth rate of 30.75%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	1.62B	0.09%
Apr 22, 2024	1.62B	-0.64%
Apr 19, 2024	1.63B	-0.38%
Apr 18, 2024	1.63B	-0.46%
Apr 17, 2024	1.64B	-
Apr 16, 2024	1.64B	-0.37%
Apr 15, 2024	1.65B	-0.69%
Apr 12, 2024	1.66B	-0.11%
Apr 11, 2024	1.66B	0.14%
Apr 10, 2024	1.66B	0.11%
Apr 9, 2024	1.66B	0.66%
Apr 8, 2024	1.64B	-0.77%
Apr 5, 2024	1.66B	0.93%
Apr 4, 2024	1.64B	-1.23%
Apr 3, 2024	1.66B	0.66%
Apr 2, 2024	1.65B	-0.06%
Apr 1, 2024	1.65B	-0.25%
Mar 28, 2024	1.66B	-0.54%
Mar 27, 2024	1.67B	0.22%
Mar 26, 2024	1.66B	0.37%
Mar 25, 2024	1.66B	0.15%
Mar 22, 2024	1.65B	-0.23%
Mar 21, 2024	1.66B	-0.08%
Mar 20, 2024	1.66B	0.02%
Mar 19, 2024	1.66B	0.14%

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Harmony Biosciences Holdings	1.66B
Amneal Pharmaceuticals	1.66B
Recursion Pharmaceuticals	1.65B
UFP Technologies	1.65B
Supernus Pharmaceuticals	1.65B
Taro Pharmaceutical Industries	1.59B
Avadel Pharmaceuticals	1.58B
Dynavax Technologies	1.56B

Market Cap Rankings